IOTOD 2009

IOTOD 2009’s practice-based sessions took an in-depth look at numerous clinical challenges: from improving safety in pharmacotherapy, to coping with acute threats to patient stability, and the management of complex patients.

The meeting’s international faculty used interactive workshops, panel discussions and plenary presentations to relate the latest scientific evidence base to delegates’ everyday clinical practice, tackling such key issues as the management of acute and chronic pain, comorbid HIV and HCV, and the effects of gender on treatment.

Chairs

Professor John Marsden

Professor of Addiction Psychology, Addictions Department, King’s College London

London, UK

Speakers

Dr Michelle Lofwall

Associate Professor of Psychiatry and Behavioral Science, Center on Drug and Alcohol Research, University of Kentucky

Lexington, KY, USA

Professor Marc Auriacombe

Professor of Psychiatry and Addiction Medicine, University of Bordeaux

Bordeaux, France

Professor Marta Torrens

Professor of Psychiatry, Autonomous University of Barcelona

Barcelona, Spain

Mr Charles Gore

Chief Executive of the Hepatitis C Trust

London, UK

Professor Traci Green

Associate Professor of Emergency Medicine and Epidemiology, Brown University and Associate Director, Boston Medical Centre Injury Prevention Research Center

USA

Dr Kathleen Carroll

Albert E Kent Professor of Psychiatry, Yale University School of Medicine

New Haven Connecticut, USA

Dr Philip Bruggmann

Arud Centres for Addiction Medicine

Zürich, Switzerland

Professor Sheila Alessi

Associate Professor, Department of Medicine and Calhoun Cardiology Center – Behavioral Health, University of Connecticut School of Medicine

Farmington, CT, USA

Professor Nancy Petry

UConn Health

Farmington, CT, USA

Dr Ed Day

Senior Lecturer, National Addiction Centre, King’s College London & Consultant in Addiction Psychiatry, Solihull Integrated Addiction Service

London, UK

Webcasts

Manoeuvres in the fog: drug-drug interactions in OST
Practicalities of transitioning between opioid agonist treatments
New horizons for treatment: translating the latest research into clinical practice
Tailoring behavioural interventions: emerging evidence and practical implications
View all webcasts